Predictive oncology stock.

Nov 24, 2023 · Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Predictive oncology stock. Things To Know About Predictive oncology stock.

Here are just a few of the top artificial intelligence (AI) stocks to buy and hold today.Predictive Oncology (): The company could be a game-changer in cancer drug development. C3.ai (): After a ...ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ...View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...See the latest Predictive Oncology Inc stock price (POAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...Stay informed on POAI stock price history, news, and more at Stocks Telegraph. Get the latest updates on Predictive Oncology for smart investing.

View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comFOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that Thomas Bock, M.D., CEO of Notable Labs, will participate in a fireside chat at the JMP …

Raymond Vennare POAI stock SEC Form 4 insiders trading. Raymond has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Raymond bought 5,000 units of POAI stock worth $2,600 on 2 December 2022.. The largest trade Raymond's ever made was buying 5,000 units …

The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...

Benzinga — Why Predictive Oncology Stock Is Getting Hammered News • Apr 13, 2023 Digiday — ‘All options are on the table’: Why Version1 is seeking a merger with another esports companyPredictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Your vote is important and easy to cast. Vote Now! Please enter your control number to view/cast your vote. Control Number. Log In ...The estimated Net Worth of Carl I. Schwartz is at least $1.22 Million dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $789,557 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model.The company owns a biorepository of tumor samples, a lab and a good manufacturing practice ...

The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ... Your vote is important and easy to cast. Vote Now! Please enter your control number to view/cast your vote. Control Number. Log In ...Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ...Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Get Predictive Oncology Inc (POAI.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsPredictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock board

The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused …The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ...Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ...Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 3:29 PM on Tuesday, Apr 4, a loss of -$0.02, or -5.88% from the previous closing price of $0.31. The stock has traded between $0.28 and $0.31 so far today. Volume today is 336,440 compared to average volume of 417,533.Press Releases. Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update. Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital. Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023.

Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...

Nov 27, 2023 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...

Predictive Oncology (NASDAQ:POAI) on Thursday said it would effect a 1-for-20 reverse stock split.The stock split will become effective on April 24. "The reverse stock split is primarily intended ...Mar 9, 2023 · EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ... Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... Get a real-time Predictive Oncology Inc. (POAI) stock price quote with breaking news, financials, statistics, charts and more.Predictive Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. POAI updated stock price target summary.On May 13, 2022, Predictive Oncology Inc. (the "Company") received a letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the bid price for the Company's common stock had closed below $1.00 per share for 30 consecutive business days, and that the Company was therefore not in ...The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass" and the word λόγος (logos), meaning "study".Cancer survival has ...About Predictive Oncology (NASDAQ: POAI) The leading edge of a new frontier in drug discovery As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to … About us Read More »Fiscal Q3 2023 ended 9/30/23. Reported on 11/14/23. Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information …

The estimated Net Worth of Carl I. Schwartz is at least $869 Thousand dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $435,062 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate.News. Get the latest Predictive Oncology Inc. (POAI) stock news and headlines to help you in your trading and investing decisions.Instagram:https://instagram. best day trading app for beginnersinsider trading stockbest mobile banking 2023nestle sa stock price Nov 24, 2023 best homeowners insurance louisianabest broker for cryptocurrency trading Predictive Oncology share price went down by -20.96% last month. The next quarterly earnings date for Predictive Oncology is scheduled on November 15, 2023. Predictive Oncology's next ex-dividend date is November 15, 2023.The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ... term life insurance lemonade 5. VanEck Biotech ETF. Total assets: $517 million. Expense ratio: 0.35%. Dividend yield: 0.35%. The VanEck Biotech ETF ( BBH 0.9%) tries to own the most liquid biotech companies based on market ...Dec 1, 2023 · Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings results on Wednesday, August, 11th. The medical instruments supplier reported ($1.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.60) by $0.60. The medical instruments supplier had revenue of $0.35 million for the quarter, compared to the ...